Anxiety Disorders Completed Phase 2 Trials for Levetiracetam (DB01202)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00141115Levetiracetam for the Treatment of Alcohol Dependence and AnxietyTreatment
NCT00612859Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)Treatment